Rezultati pretrage - Mitani, Hiroki
- Prikaz rezultata 1 – 12 od 12
-
1
Mycophenolate mofetil as a successful treatment of corticosteroid-resistant immune checkpoint inhibitor-induced hepatitis od Nakano, Kenji, Nishizawa, Masatoshi, Fukuda, Naoki, Urasaki, Tetsuya, Wang, Xiaofei, Mitani, Hiroki, Takahashi, Shunji
Izdano 2020Tekst -
2
Two Cases of Ectopic Hamartomatous Thymoma Masquerading as Sarcoma od Kondo, Takahito, Sato, Yukiko, Tanaka, Hiroko, Sasaki, Toru, Kawabata, Kazuyoshi, Mitani, Hiroki, Yonekawa, Hiroyuki, Fukushima, Hirofumi, Shimbashi, Wataru
Izdano 2017Tekst -
3
TERT Promoter Mutation and Extent of Thyroidectomy in Patients with 1–4 cm Intrathyroidal Papillary Carcinoma od Ebina, Aya, Togashi, Yuki, Baba, Satoko, Sato, Yukiko, Sakata, Seiji, Ishikawa, Masashi, Mitani, Hiroki, Takeuchi, Kengo, Sugitani, Iwao
Izdano 2020Tekst -
4
Indwelling voice prosthesis insertion after total pharyngolaryngectomy with free jejunal reconstruction od Fukushima, Hirofumi, Kanazawa, Takeharu, Kawabata, Kazuyoshi, Mitani, Hiroki, Yonekawa, Hiroyuki, Sasaki, Toru, Shimbashi, Wataru, Seto, Akira, Kamiyama, Ryousuke, Misawa, Kiyoshi, Asakage, Takahiro
Izdano 2017Tekst -
5
Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer od SATO, YASUYOSHI, FUKUDA, NAOKI, FUJIWARA, YU, WANG, XIAOFEI, URASAKI, TETSUYA, OHMOTO, AKIHIRO, NAKANO, KENJI, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Izdano 2021Tekst -
6
Efficacy of Nivolumab for Head and Neck Cancer Patients with Primary Sites and Histological Subtypes Excluded from the CheckMate-141 Trial od Sato, Yasuyoshi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Ohmoto, Akihiro, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Sato, Yukiko, Mitani, Hiroki, Tomomatsu, Junichi, Takahashi, Shunji
Izdano 2020Tekst -
7
Comparison of the efficacy and safety of the EXTREME regimen for treating recurrent or metastatic head and neck squamous cell carcinoma in older and younger adult patients od Fukuda, Naoki, Yunokawa, Mayu, Fujiwara, Yu, Wang, Xiaofei, Ohmoto, Akihiro, Hayashi, Naomi, Urasaki, Tetsuya, Sato, Yasuyoshi, Nakano, Kenji, Ono, Makiko, Tomomatsu, Junichi, Mitani, Hiroki, Takahashi, Shunji
Izdano 2020Tekst -
8
Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for Anaplastic Thyroid Cancer Treated With Lenvatinib od FUKUDA, NAOKI, TODA, KAZUHISA, FUJIWARA, YU, WANG, XIAOFEI, OHMOTO, AKIHIRO, URASAKI, TETSUYA, HAYASHI, NAOMI, SATO, YASUYOSHI, NAKANO, KENJI, YUNOKAWA, MAYU, ONO, MAKIKO, TOMOMATSU, JUNICHI, MITANI, HIROKI, TAKAHASHI, SHUNJI
Izdano 2020Tekst -
9
Clinical Impact of Cachexia in Head and Neck Cancer Patients Who Received Chemoradiotherapy od Hayashi, Naomi, Sato, Yasuyoshi, Fujiwara, Yu, Fukuda, Naoki, Wang, Xiaofei, Nakano, Kenji, Urasaki, Testuya, Ohmoto, Akihiro, Ono, Makiko, Tomomatsu, Junichi, Sato, Yukiko, Mitani, Hiroki, Toshiyasu, Takashi, Takahashi, Shunji
Izdano 2021Tekst -
10
Clinicopathological and genomic features in patients with head and neck neuroendocrine carcinoma od Ohmoto, Akihiro, Sato, Yukiko, Asaka, Reimi, Fukuda, Naoki, Wang, Xiaofei, Urasaki, Tetsuya, Hayashi, Naomi, Sato, Yasuyoshi, Nakano, Kenji, Yunokawa, Mayu, Ono, Makiko, Tomomatsu, Junichi, Toshiyasu, Takashi, Mitani, Hiroki, Takeuchi, Kengo, Mori, Seiichi, Takahashi, Shunji
Izdano 2021Tekst -
11
Weekly Cisplatin Plus Radiation for Postoperative Head and Neck Cancer (JCOG1008): A Multicenter, Noninferiority, Phase II/III Randomized Controlled Trial od Kiyota, Naomi, Tahara, Makoto, Mizusawa, Junki, Kodaira, Takeshi, Fujii, Hirofumi, Yamazaki, Tomoko, Mitani, Hiroki, Iwae, Shigemichi, Fujimoto, Yasushi, Onozawa, Yusuke, Hanai, Nobuhiro, Ogawa, Takenori, Hara, Hiroki, Monden, Nobuya, Shimura, Eiji, Minami, Shujiro, Fujii, Takashi, Tanaka, Kaoru, Homma, Akihiro, Yoshimoto, Seiichi, Oridate, Nobuhiko, Omori, Koichi, Ueda, Tsutomu, Okami, Kenji, Ota, Ichiro, Shiga, Kiyoto, Sugasawa, Masashi, Asakage, Takahiro, Saito, Yuki, Murono, Shigeyuki, Nishimura, Yasumasa, Nakamura, Kenichi, Hayashi, Ryuichi
Izdano 2022Tekst -
12
Transoral surgery for superficial head and neck cancer: National Multi‐Center Survey in Japan od Katada, Chikatoshi, Muto, Manabu, Fujii, Satoshi, Yokoyama, Tetsuji, Yano, Tomonori, Watanabe, Akihito, Iizuka, Toshiro, Yoshinaga, Shigetaka, Tateya, Ichiro, Mitani, Hiroki, Shimizu, Yuichi, Takahashi, Akiko, Kamijo, Tomoyuki, Hanaoka, Noboru, Abe, Makoto, Shiotani, Akihiro, Kano, Koichi, Asada, Yukinori, Matsuhashi, Tamotsu, Umeno, Hirohito, Okami, Kenji, Goda, Kenichi, Hori, Shinichiro, Ono, Yoichiro, Terai, Shuji, Nagami, Yasuaki, Takemura, Kenichi, Kawada, Kenro, Ando, Mizuo, Shimeno, Naoto, Arai, Akihito, Sakamoto, Yasutoshi, Ichinoe, Masaaki, Nemoto, Tetsuo, Fujita, Masahiro, Watanabe, Hidenobu, Shimoda, Tadakazu, Ochiai, Atsushi, Kato, Takakuni, Hayashi, Ryuichi
Izdano 2021Tekst